Breast Cancer Drugs Market – Global Industry Perspective Comprehensive Analysis and Forecast, 2015 to 2021

Report Code: ZMR-70 | Report Format : | Status : Upcoming |

Abstract

Breast cancer is a malignant cell growth in the breast. Breast cancer can begin in different areas of the breast — the ducts, the lobules, or in some cases, the tissue. Sign of breast cancer include lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple etc.  Breast cancer most commonly develops in cell from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas. Breast cancer is the most common cancer among women worldwide and the second-most common cancer overall. Incidence of breast cancer rise after the age 50 who have been through the menopause. About 8 out of 10 cases of breast cancer occur in women over the age of 50. Diagnosis of breast cancer is confirmed by physical examination, imaging test, or taking biopsy.

Breast cancer market is driven by increasing incidence of cancer cases (% increase in elder women in all countries) across globe. Moreover, increasing awareness, government initiative, and improved health care facilities influence the breast cancer drug market. However, high cost of treatment and limited awareness are major restraining factors in the growth of breast cancer drug market over the years. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies is expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the breast cancer drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the breast cancer drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein treatment segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides detailed segmentation of the breast cancer drug market based on treatment and region.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America and Europe were the leading regional segments of breast cancer drug market in 2015 on account of the high number of reported cases and easy affordability of the drugs in these regions. Moreover, technological advancement and strong demand of diagnostic test would also account for market growth. The breast cancer drug market is expected to witness the highest growth in Asia-Pacific region in upcoming years due to excessive increase of health care infrastructure, growing percentage of population, and increase in disposal income among the population.

The report covers scenario including the company overviews, financial revenues of the key participants. Key players of breast cancer drug market included in report are GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd, Actavis, Inc., Bristol-Myers Squibb Company, Hospira, Inc., Bayer AG, Accord Healthcare, Inc. and Gilead Sciences, Inc. 

This report segments the breast cancer drug market are follows:

Breast Cancer Drug Market: Treatment Segment Analysis

  • Targeted therapy
  • Chemotherapy
  • Surgery & radiation therapy
  • Hormonal therapy

Breast Cancer Drug Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia pacific
  • Latin America
  • Middle east & Africa

Related Reports

Mycology Immunoassays Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2486 | Report Format:

Mycology Immunoassays Testing Market: Overview The term mycology deals with the study of the fungus. In case of diagnosis of any type of infection, microscopy, histopathology, and the use of the fungal-specific stains have an important role. For the proper therapy, accurate and early diagnosis o...Read More

Animal Auto-Immune Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2484 | Report Format:

Animal Auto-Immune Disease Diagnostics Market: Overview When ananimal is suffering from the auto-immune diseases then, in that case, the body tissues lose the ability to identify foreign antigens and starts attacking the healthy tissues. Some of the popular animal auto-immune diseases are autoim...Read More

Decubitus Ulcer Treatment Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2482 | Report Format:

Decubitus Ulcer Treatment Products Market: Overview The alternative names for decubitus ulcers are pressure sores and bed sores. They are wounds that are open which are present on the skin that covers the bony area. It is caused due to the continuous pressure which is owing to the lack of blood ...Read More

Computer Assisted Anesthesia Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2409 | Report Format:

Computer Assisted Anesthesia Systems Market: Overview The developments in the digital surgical methods have changed significantly one such development is the computer assisted technology systems. Among them, one of the developments is the computer assisted anesthesia systems. The computer assist...Read More

Amniotic Membrane Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2407 | Report Format:

Amniotic Membrane Market: Overview The innermost layer of the placenta that facilitates the development of the fetus during the period of pregnancy is called amniotic membrane. The amniotic membrane constitutes an avascular stromal matrix, a single epithelium layer, and a thick basement membrane...Read More

Choose License Type:
Latest Published Reports

View All Published Reports